VOLT-02
Chemical compound
- 2763338-59-4
VOLT-02 is a water-soluble conjugate of progesterone and a neurosteroid which is under development by Levolta Pharmaceuticals (formerly Voltarra Pharmaceuticals) for the treatment of traumatic brain injury, gynecological disorders, and menstrual disorders.[1] As of March 2017, it is in phase II clinical trials for these indications.[1] The chemical structure of VOLT-02 does not appear to have been released yet.[1]
See also
- List of neurosteroids § Inhibitory > Synthetic > Pregnanes
- List of progestogen esters § Oximes of progesterone derivatives
- List of investigational sex-hormonal agents § Progestogenics
References
- ^ a b c "Progesterone conjugate - Levolta Pharmaceuticals - AdisInsight". adisinsight.springer.com.
External links
- Pipeline - Levolta Pharmaceuticals
- Progesterone conjugate (VOLT-02) - Levolta Pharmaceuticals
- v
- t
- e
Progesterone receptor modulators
(PAQRTooltip Progestin and adipoQ receptor)
| Agonists | |
|---|---|
| Antagonists |
- See also
- Receptor/signaling modulators
- Progestogens and antiprogestogens
- Androgen receptor modulators
- Estrogen receptor modulators
- List of progestogens
 | This article about a steroid is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e
 | This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e
